Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00101153
First received: January 7, 2005
Last updated: July 22, 2015
Last verified: July 2015